Cargando…

Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload–induced Cardiac Hypertrophy and Remodeling in Male Mice

We previously showed that Qiliqiangxin (QL) capsules could ameliorate cardiac hypertrophy and remodeling in a mouse model of pressure overload. Here, we compared the effects of QL alone with those of QL combined with the following 3 types of antihypertensive drugs on cardiac remodeling and dysfuncti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Yong, Gong, Hui, Wang, Xingxu, Wu, Jian, Wang, Shijun, Yuan, Jie, Yin, Peipei, Jiang, Guoliang, Li, Yang, Ding, Zhiwen, Zhang, Weijing, Zhou, Jingmin, Ge, Junbo, Zou, Yunzeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Cardiovascular Pharmacology 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461387/ https://www.ncbi.nlm.nih.gov/pubmed/25806688 http://dx.doi.org/10.1097/FJC.0000000000000230

Ejemplares similares

Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6
por: Zhou, Jingmin, et al.
Publicado: (2015)

Caspase-1 Abrogates the Salutary Effects of Hypertrophic Preconditioning in Pressure Overload Hearts via IL-1β and IL-18
por: Dai, Fangjie, et al.
Publicado: (2021)

Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats
por: Wang, Jingfeng, et al.
Publicado: (2017)

Pressure overload promotes cystatin C secretion of cardiomyocytes to regulate the MAPK signaling pathway and mediate cardiac hypertrophy
por: Shen, Yi, et al.
Publicado: (2020)

Qiliqiangxin attenuates hypoxia‐induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF‐1α‐dependent glycolysis
por: Wang, Yanyan, et al.
Publicado: (2018)

Protective Effect of Qiliqiangxin Capsule on Energy Metabolism and Myocardial Mitochondria in Pressure Overload Heart Failure Rats
por: Zhang, Junfang, et al.
Publicado: (2013)

Qiliqiangxin Affects L Type Ca(2+) Current in the Normal and Hypertrophied Rat Heart
por: Wei, Yidong, et al.
Publicado: (2012)

Extracellular high‐mobility group box 1 mediates pressure overload‐induced cardiac hypertrophy and heart failure
por: Zhang, Lei, et al.
Publicado: (2015)

Src Is Required for Mechanical Stretch-Induced Cardiomyocyte Hypertrophy through Angiotensin II Type 1 Receptor-Dependent β-Arrestin2 Pathways
por: Wang, Shijun, et al.
Publicado: (2014)

Qiliqiangxin protects against anoxic injury in cardiac microvascular endothelial cells via NRG‐1/ErbB‐PI3K/Akt/mTOR pathway
por: Wang, Jingfeng, et al.
Publicado: (2017)

Qiliqiangxin Improves Cardiac Function through Regulating Energy Metabolism via HIF-1α-Dependent and Independent Mechanisms in Heart Failure Rats after Acute Myocardial Infarction
por: Wang, Yanyan, et al.
Publicado: (2020)

Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice
por: Tao, Lichan, et al.
Publicado: (2015)

Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats
por: Wang, Hui, et al.
Publicado: (2017)

Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure
por: Lu, Yingdong, et al.
Publicado: (2022)

Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats
por: Sun, Xutao, et al.
Publicado: (2020)

Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy
por: Ma, Sai, et al.
Publicado: (2021)

Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling
por: Liu, Xin, et al.
Publicado: (2021)

The Electrophysiological Effects of Qiliqiangxin on Cardiac Ventricular Myocytes of Rats
por: Wei, Yidong, et al.
Publicado: (2013)

HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in vitro via the RAGE/ERK1/2 signaling pathway
por: Zhang, Lei, et al.
Publicado: (2019)

Heat shock transcription factor 1 protects against pressure overload-induced cardiac fibrosis via Smad3
por: Zhou, Ning, et al.
Publicado: (2017)

Future prospects of Qiliqiangxin on heart failure: epigenetic regulation of regeneration
por: Tao, Lichan, et al.
Publicado: (2013)

Heat‐shock transcription factor 1 is critically involved in the ischaemia‐induced cardiac hypertrophy via JAK2/STAT3 pathway
por: Yuan, Lingyan, et al.
Publicado: (2018)

A protective role of ciglitazone in ox-LDL-induced rat microvascular endothelial cells via modulating PPARγ-dependent AMPK/eNOS pathway
por: Xu, Lei, et al.
Publicado: (2015)

PCSK9 participates in oxidized‐low density lipoprotein‐induced myocardial injury through mitochondrial oxidative stress and Drp1‐mediated mitochondrial fission
por: Li, Xuan, et al.
Publicado: (2022)

Diet-induced obesity promotes altered remodeling and exacerbated cardiac hypertrophy following pressure overload
por: Holzem, Katherine M, et al.
Publicado: (2015)

Left ventricular response in the transition from hypertrophy to failure recapitulates distinct roles of Akt, β-arrestin-2, and CaMKII in mice with aortic regurgitation
por: Wu, Jian, et al.
Publicado: (2020)

Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats
por: Chen, Huiyang, et al.
Publicado: (2019)

Transfer of Bone-Marrow-Derived Mesenchymal Stem Cells Influences Vascular Remodeling and Calcification after Balloon Injury in Hyperlipidemic Rats
por: Liao, Jianquan, et al.
Publicado: (2012)

Peroxisome Proliferator-Activated Receptor-γ Antagonizes LOX-1-Mediated Endothelial Injury by Transcriptional Activation of miR-590-5p
por: Xu, Lei, et al.
Publicado: (2019)

Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ
por: Wu, Xiaodong, et al.
Publicado: (2021)

Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload
por: Zou, Yan, et al.
Publicado: (2021)

High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway
por: Lin, Li, et al.
Publicado: (2015)

Left ventricular remodeling with preserved function after coronary microembolization: the effect of methylprednisolone
por: Ma, Jianying, et al.
Publicado: (2014)

Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes
por: Xu, Ran, et al.
Publicado: (2021)

Qiliqiangxin Capsules Optimize Cardiac Metabolism Flexibility in Rats With Heart Failure After Myocardial Infarction
por: Cheng, Wenkun, et al.
Publicado: (2020)

Identification of Differential Expression Genes between Volume and Pressure Overloaded Hearts Based on Bioinformatics Analysis
por: Fu, Yuanfeng, et al.
Publicado: (2022)

Microtubule Stabilization in Pressure Overload Cardiac Hypertrophy
por: Sato, Hiroshi, et al.
Publicado: (1997)

The role of androgens in pressure overload myocardial hypertrophy
por: Schafstedde, Marie, et al.
Publicado: (2023)

Up-regulation of BMP-2 antagonizes TGF-β1/ROCK-enhanced cardiac fibrotic signalling through activation of Smurf1/Smad6 complex
por: Wang, Shijun, et al.
Publicado: (2012)

Variations in Energy Metabolism Precede Alterations in Cardiac Structure and Function in Hypertrophic Preconditioning
por: Wu, Jian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_45nrpr1loe01796lior3heg8tk